Universal Access and Affordable Medicines
Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.
About our work on access to medicines
Publications
Latest Developments
Transparency is a fundamental pillar for the success of the EU Vaccines Strategy
39 health and consumer organisations call for the public and their elected representatives to be given more scrutiny of EU COVID19 vaccine contracts
Putting medicines policy under the spotlight: EPHA’s #A2MDialogues
EPHA’s new series of online discussions, putting the spotlight on actionable solutions on access to medicines for decision-makers in Europe.
Recommendations for unleashing meaningful innovation through regulatory reform
A series of recommendations to generate better evidence on new medicines developed during the the first of the EPHA #A2MDialogues “Unleashing meaningful innovation through regulatory reform.”
Analysis & Opinion
Best treatment for cancer patients in Europe?
If the EU wants to ensure “access to the best treatment for all” in its “Europe’s Beating Cancer plan” what changes need to be made to the assessment process for new cancer treatments?
The European Pharmaceutical Strategy: An inventory for action for Europe
What could we hope for from the upcoming EU Pharmaceutical Strategy, expected on 24 November
Getting it right: COVID19 vaccines procurement
How should the European Commission and Member States manage the process of finding vaccines to tackle COVID-19? EPHA sets out 9 recommendations the European Commission and national governments should full to protect the public interest.
Events
Register below for EPHA’s new series of #A2M Dialogues
A new series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.
Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.

Unleashing meaningful innovation through regulatory reform
19 October 2020
17:00-18:00

The EU's IP strategy: Enabler or barrier?
27 October 2020
17:00-18:00

Pharma & COVID19: Winners, losers, prospects
19 November 2020
16:00-17:00

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
25 November 2020
16:00-17:30
Get monthly updates on key public health issues!
Past Events
Time for a new deal
14 November 2019
4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Putting health first
3 June 2019
Trailblazers, routes to better and affordable medicines by 2025
20 November 2018
How good are our medicines?
3 October 2018
Game changers for better and affordable medicines in Europe
21 November 2017
At the European Health Forum Gastein
How good are our medicines? An operational agenda for EU & national policy-makers
Medicines: new games, new rules - Pathways to better and affordable medicines.
“Healthy" innovation: putting patients before profits
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
Yannis Natsis
Policy Manager
yannis@epha.org
+32 2 233 3886